Loteprednol

Loteprednol Overview

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt...

Read more Loteprednol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loteprednol

Recent Loteprednol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Loteprednol

Gel: 0.38%, 0.5%
Ointment: 0.5%
Suspension: 0.2%, 0.5%
Suspension/drops: 0.2%, 0.20%, 0.5%, 0.50%, 1%

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Loteprednol: (1 result)

Sorted by National Drug Code

68682-299 Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Oceanside Pharmaceuticals

Other drugs which contain Loteprednol or a similar ingredient: (6 results)

ALREX Loteprednol1 discussion
INVELTYS Loteprednol Etabonate
LOTEMAX Loteprednol1 discussion
LOTEMAX SM Loteprednol Etabonate
LOTEPREDNOL + TOBRAMYCIN
ZYLET Loteprednol + Tobramycin